Cingulate Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0TTM through 30 Jun 2026
Net Income -$28.8MTTM through 30 Jun 2026
Free Cash Flow -$20.9MTTM through 30 Jun 2026
Margins
| Current |
|---|
Returns
-122.7%ROE
-87.1%ROA
Balance Sheet Health
Debt / Equity0.32x
Current Ratio3.50x
Net Debt-$19.8Mnet cash position
Cash & Equivalents$28.4M
Quality Metrics
Altman Z-Score-3.27
Piotroski F-Score2 / 9
Earnings-Beat Rate25.0%
Multi-Year Trend
Diluted EPS-$3.56TTMFY2025: $-4.44
Dividend
No dividend
Capital Allocation
R&D Spend$8.5M
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.